Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Oct 01 2024

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-01-2024-5

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 01, 2024, titled "Aurobindo Pharma receives USFDA Approval for Cephalexin Tablets USP, 250 mg and 500 mg".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases